Saccharomyces cerevisiae &bgr;-Carbonic Anhydrase: Inhibition and Activation Studies

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|16|29|3327-3336

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.16, Iss.29, 2010-10, pp. : 3327-3336

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Saccharomyces cerevisiae GSK-3&bgr; Homologs

By  

Current Drug Targets, Vol. 7, Iss. 11, 2006-11 ,pp. : 1455-1465

Bentham Science Publishers

Access to resources Recommend Favorite

Carbonic Anhydrase Activation and the Drug Design

By  

Current Pharmaceutical Design, Vol. 14, Iss. 7, 2008-03 ,pp. : 708-715

Bentham Science Publishers

Access to resources Recommend Favorite

Carbonic Anhydrase Inhibition/Activation: Trip of a Scientist Around the World in the Search of Novel Chemotypes and Drug Targets

By  

Current Pharmaceutical Design, Vol. 16, Iss. 29, 2010-10 ,pp. : 3233-3245

Bentham Science Publishers

Access to resources Recommend Favorite

Carbonic anhydrase inhibition as a cancer therapy: a review of patent literature, 2007 – 2009

By Poulsen Sally-Ann  

Expert Opinion on Therapeutic Patents, Vol. 20, Iss. 6, 2010-06 ,pp. : 795-806

Informa Healthcare

Access to resources Recommend Favorite

The Alpha-Carbonic Anhydrase from the Malaria Parasite and its Inhibition

By  

Current Pharmaceutical Design, Vol. 14, Iss. 7, 2008-03 ,pp. : 631-640

Bentham Science Publishers

Access to resources Recommend Favorite